SOD1 and hyperlipidemia: Meanwhile, MDA level decreased (vs hyperlipidemia group, P<0.01, Figure 8A) while SOD concentration increased significantly (vs hyperlipidemia group, P<0.05 or 0.01, Figure 8B) in the UAG treated group with different doses.